ArticleAnnals of transplantation2026
A New Lifeline: Feasibility and Outcomes of Altruistic Donor Programs in Living-Donor Liver Transplantation, A Single Saudi Center Experience.
Article in Annals of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND In regions with limited deceased-donor liver transplantation, living-donor liver transplantation is often the only viable option. Altruistic (unrelated, nondirected) living-donor liver donation offers a novel strategy to expand the donor pool, particularly for patients lacking suitable related donors. MATERIAL AND METHODS This retrospective study analyzed all altruistic liver donors and their recipients at King Fahad Specialist Hospital-Dammam between April 2018 and December 2024. Donors underwent medical, psychosocial, and ethical evaluations, with final approval by an independent multidisciplinary committee. Data on donor demographics, hospital stay, complications, and graft type were reviewed. RESULTS Thirty-two altruistic donors (mean age 34.6 years; 68.8% male) successfully donated left lateral liver grafts. Allocation prioritized pediatric and high-urgency recipients. The average donor hospital stay was 4 days. No major complications (Clavien-Dindo grade ≥III) occurred; 81.2% had no complications, and 18.8% had minor (grade I-II) issues. All donors were alive and well at follow-up. CONCLUSIONS Altruistic liver donation is a safe, ethical, and effective strategy to address organ shortages for liver transplantation. With strong oversight and donor screening, this model enables life-saving transplants in vulnerable populations and represents a replicable innovation in transplant care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.